Elizabeth E. Reed - 10 May 2022 Form 4 Insider Report for Travere Therapeutics, Inc. (TVTX)

Role
SVP, GC & Corporate Secretary
Signature
/s/ Elizabeth E. Reed
Issuer symbol
TVTX
Transactions as of
10 May 2022
Net transactions value
-$41,943
Form type
4
Filing time
12 May 2022, 20:47:35 UTC
Previous filing
02 Feb 2022
Next filing
26 Jan 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TVTX Common Stock Sale $19,359 -900 -2.1% $21.51 42,888 10 May 2022 Direct F1
transaction TVTX Common Stock Sale $22,584 -1,050 -2.4% $21.51 41,838 12 May 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales reported were made pursuant to a written plan meeting the requirements of Rule 10b5-1(c) of the Securities Exchange Act of 1934, as amended, and includes the sale of shares to cover the tax obligation that occurred upon the vesting of restricted stock units.